
From 1977 to 1982, 62 patients with various advanced zzso solid tumors were treated by zzso therapy and totally 129 courses were zzso Majority of the patients suffered from zzso zzso zzso zzso zzso zzso lung cancer zzso zzso cancer zzso breast cancer zzso and zzso melanoma zzso All were confirmed by zzso or pathology except one primary liver zzso There were clinically measurable zzso in 59 patients for evaluation of the treatment, and 3 zzso zzso patients without zzso were given a zzso zzso zzso 33 out of 62 had received chemotherapy and/or zzso zzso zzso of zzso ranged from 2 to 3 zzso per course in most patients and dose of zzso from 9 to 12 zzso every 6 hours for 3 zzso 2 zzso patients achieved complete zzso (1 zzso zzso and 1 zzso zzso and 8 zzso partial zzso (1 zzso zzso 5 zzso lymphoma, 1 zzso cancer and 1 breast zzso with a total response rate of zzso No response was observed in all 16 lung zzso The main side effects of zzso therapy were zzso zzso zzso of zzso zzso zzso zzso skin zzso fever and zzso All patients were followed more than 3 zzso 4 patients are still alive zzso 9, 4 and 7 years, respectively), including 3 zzso zzso patients who received zzso zzso chemotherapy and 1 zzso zzso 

